These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory. Preljevic VT, Østhus TB, Sandvik L, Opjordsmoen S, Nordhus IH, Os I, Dammen T. J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418 [Abstract] [Full Text] [Related]
23. Sex differences in inpatients with major depression. Zetin M, Sklansky GJ, Cramer M. J Clin Psychiatry; 1984 Jun; 45(6):257-9. PubMed ID: 6144672 [Abstract] [Full Text] [Related]
24. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Bose A, Korotzer A, Gommoll C, Li D. Depress Anxiety; 2008 Jun; 25(10):854-61. PubMed ID: 18050245 [Abstract] [Full Text] [Related]
25. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression. Vaccarino AL, Evans KR, Sills TL, Kalali AH. Depress Anxiety; 2008 Jun; 25(12):1006-13. PubMed ID: 18800370 [Abstract] [Full Text] [Related]
26. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. Lueboonthavatchai P. J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438 [Abstract] [Full Text] [Related]
27. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up. Knekt P, Lindfors O, Härkänen T, Välikoski M, Virtala E, Laaksonen MA, Marttunen M, Kaipainen M, Renlund C, Helsinki Psychotherapy Study Group. Psychol Med; 2008 May; 38(5):689-703. PubMed ID: 18005493 [Abstract] [Full Text] [Related]
28. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV. Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [Abstract] [Full Text] [Related]
29. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Mehnert A, Koch U. Psychooncology; 2007 Mar; 16(3):181-8. PubMed ID: 16856147 [Abstract] [Full Text] [Related]
30. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service. Graystone HJ, Garner MJ, Baldwin DS. J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267 [Abstract] [Full Text] [Related]
31. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, Fricchione GL. Am J Cardiol; 2006 Aug 01; 98(3):319-24. PubMed ID: 16860016 [Abstract] [Full Text] [Related]
32. Effect of levetiracetam on depression and anxiety in adult epileptic patients. Mazza M, Martini A, Scoppetta M, Mazza S. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):539-43. PubMed ID: 18031881 [Abstract] [Full Text] [Related]
33. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM. Psychopharmacol Bull; 2007 Feb 15; 40(1):47-56. PubMed ID: 17285095 [Abstract] [Full Text] [Related]
34. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial]. Kiejna A, Małyszczak K, Rzewuska M, Sobucka K, Florkowski A, Rajewski A, Rajewska J, Wojtanowska M, Dabkowski M, Brzeziński R, Rybakowski J, Sep-Kowalikowa B, Gałuszko P, Nowicki Z. Psychiatr Pol; 1996 Feb 15; 30(6):973-92. PubMed ID: 9132771 [Abstract] [Full Text] [Related]
35. [Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms]. Banaś A, Januszkiewicz-Grabias A, Radziwiłłowicz P, Smoczyński S. Psychiatr Pol; 2002 Feb 15; 36(6 Suppl):323-9. PubMed ID: 12647456 [Abstract] [Full Text] [Related]
36. Cross-sectional assessment of psychiatric disorders in renal transplantation patients in Turkey: a preliminary study. Arapaslan B, Soykan A, Soykan C, Kumbasar H. Transplant Proc; 2004 Jun 15; 36(5):1419-21. PubMed ID: 15251349 [Abstract] [Full Text] [Related]
37. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. Bossola M, Ciciarelli C, Di Stasio E, Conte GL, Vulpio C, Luciani G, Tazza L. Gen Hosp Psychiatry; 2010 Jun 15; 32(2):125-31. PubMed ID: 20302985 [Abstract] [Full Text] [Related]
38. Rasch analysis of the scoring scheme of the HADS Depression subscale in Chinese stroke patients. Tang WK, Wong E, Chiu HF, Ungvari GS. Psychiatry Res; 2007 Feb 28; 150(1):97-103. PubMed ID: 17267049 [Abstract] [Full Text] [Related]
39. Mixed anxiety and depression: from theory to practice. Boulenger JP, Fournier M, Rosales D, Lavallée YJ. J Clin Psychiatry; 1997 Feb 28; 58 Suppl 8():27-34. PubMed ID: 9236733 [Abstract] [Full Text] [Related]
40. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G. Hum Psychopharmacol; 2008 Jun 28; 23(4):313-9. PubMed ID: 18327889 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]